Kraig Labs said the resounding successes of the production trials put it in a strong position to accelerate its 2024 production schedule of spider silk.

This production cycle serves as a critical transition for the Company’s commercialization of sustainable and cost-effective spider silk production.

It marks the first transition of true production hybrids to the manufacturing environment. This rearing cycle also represents more than a 10X increase in production over the spring trials and is the largest single batch of spider silk production in the Company’s operating history.

The BAM-1 hybrids were created by integrating the Company’s recombinant spider silk technology, Dragon SilkTM, into two robust commercial silkworm strains. These two silkworm strains created the parental lines that, when combined, produce the BAM-1 hybrids. T

he BAM-1 hybrids result in the largest cocoons and most robust silkworms Kraig Labs has produced. This, in turn, results in higher silk yield and improved production efficiency, while maintaining fiber material performance, as the Company scales up its spider silk production operations.

“This successful launch of the BAM-1 hybrids is the result of more than a year of focused development by our team. The spring production trials demonstrated that we have brought together the right team, the right technology, and the right facilities to make 2024 a breakout year for the commercialization of spider silk,” said Founder and CEO of Kraig Labs, Kim Thompson. “This cycle puts us securely on the path to reaching our first production milestone of a metric ton of spider silk.”

In February 2024, Kraig Labs acquired a new recombinant spider silk production centre in Lam Dong Province, Vietnam to serve as the centre of operations for the distribution and collection of the company’s spider silk fibres, yarns and fabrics.